evc8k.pdf -- Converted by SECPublisher 4.0, created by BCL Technologies Inc., for SEC Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 7, 2006

EATON VANCE CORP.
(Exact name of registrant as specified in its charter)

            Maryland                  1-8100                    04-2718215 



(State or other jurisdiction 
 of incorporation) 
  (Commission File Number)    (IRS Employer Identification No.) 
       
 
 
                   255 State Street, Boston, Massachusetts                       02109 
                     (Address of principal executive offices)                    (Zip Code) 

Registrant’s telephone number, including area code: (617) 482-8260

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[  ]   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 
[  ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 
[  ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act 
       (17 CFR 240.14d-2(b)) 
[  ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act 
       (17 CFR 240.13e-4(c)) 

Page 1 of 5


                             INFORMATION INCLUDED IN THE REPORT 
 
 
Item 5.02    Departure of Directors or Principal Officers; Election of Directors; Appointment of 
Principal Officers 
   

                          Registrant announced the election of Dorothy E. Puhy as Director, as described in
Registrant’s news release dated April 7, 2006, a copy of which is filed herewith as Exhibit 99.1 and
incorporated herein by reference.

Item 9.01    Financial Statements and Exhibits 
    Exhibit No.    Document 
    99.1    Press Release issued by the Registrant dated April 7, 2006 
announcing the election of Dorothy E. Puhy as Director. 
       

Page 2 of 5


                                                               SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

        EATON VANCE CORP. 
        (Registrant) 
 
 
Date:    April 7, 2006    /s/ William M. Steul 

        William M. Steul, Chief Financial Officer 

 

 

 

                                                                   Page 3 of 5


                                                         EXHIBIT INDEX

          Each exhibit is listed in this index according to the number assigned to it in the exhibit table set
forth in Item 601 of Regulation S-K. The following exhibit is filed as part of this Report:

Exhibit No.    Description 
 
99.1    Copy of Registrant's news release dated April 7, 2006 announcing the election of 
Dorothy E. Puhy as Director. 
   

 

 

 

 

                                                              Page 4 of 5


Exhibit 99.1

NEWS RELEASE     
Eaton Vance Corp.     
The Eaton Vance Building     
255 State Street, Boston, MA  02109 
(617) 598-8036     
Contact: Meg Pier     
 
 
                                     April 7, 2006     

FOR IMMEDIATE RELEASE

DOROTHY E. PUHY
ELECTED DIRECTOR OF Eaton Vance Corp.

Boston, MA - Eaton Vance Corp., a Boston-based investment management firm with approximately $113 billion of assets under management on January 31, 2006, today announced the election of Dorothy E. Puhy, age 54, to its Board of Directors on April 3, 2006. Ms. Puhy is the Executive Vice President and Chief Financial Officer of Dana-Farber Cancer Institute, Inc., in Boston.

“Dorothy's exceptional financial and business experience and skills should serve Eaton Vance shareholders well. She is another strong addition to our Board,” said James B. Hawkes, Eaton Vance’s Chairman and Chief Executive Officer.

The election of Ms. Puhy increases the number of independent directors of Eaton Vance Corp. from five to six; there are two inside directors. It is expected that Ms. Puhy will be appointed as a member of the Compensation Committee and of the Nominating and Governance Committee of the Board.

Ms. Puhy has served as Executive Vice President and Chief Financial Officer of Dana-Farber Cancer Institute since 1994. Previously she served as Chief Financial Officer of Tufts-New England Medical Center for nine years. She is a member of the Board of ABIOMED, Inc., CRICO (Controlled Risk Insurance Company), and Crittenton. Ms. Puhy earned her B.A. from University of Pennsylvania and an MBA from Wharton Graduate School.

Eaton Vance Corp. is traded on the New York Stock Exchange under the symbol EV.

Page 5 of 5